Medical Research
(H80)
OXFENDAZOLE DEVELOPMENT GROUP
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$59K
Total Revenue
$605K
Total Expenses
$1.1M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.0%
Fundraising Efficiency
0.0%
Operating Reserve
22.76x
Liability-to-Asset
0.0%
Revenue Diversification
85.3%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $59K | $605K | $1.1M | 98.0% | 0 |
| 2022 | $1.7M | $43K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.